Insecticide component found in Indian cough syrup

Tashkent: Startling revelations have emerged during the investigation against an Indian pharmaceutical company, as suspicions of profiting from substandard cough syrup led to the use of insecticide components, resulting in the deaths of 65 children in Uzbekistan.

According to details, the CEO of the Indian-origin Caramex Pharmaceuticals, Mr. Singh, had signed a deal with his own country's company, Mirion BioTech, to produce low-quality cough syrup.

Driven by the desire for greater gains, the company surreptitiously introduced insecticide components into the syrup.

Chief Operating Officer, Mr. Tar Singh, admitted to bribery and revealed that he had bribed Uzbek authorities with $33,000 to overlook quality tests.

Uzbek authorities reported that Caramex manipulated the syrup's price for tax evasion as well.

It is worth noting that in December 2022, 65 children in Uzbekistan died due to the use of cough syrup, raising suspicions.

Following the scandal's exposure, several countries including the United States and the European Union suspended the license of the Indian company Mirion BioTech.